Drug intelligence / Profile preview

oximinoarylsulfonamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

Oximinoarylsulfonamide is an experimental small molecule compound characterized by the presence of both oxime and aryl sulfonamide functional groups. Its chemical formula is C34H46N6O6S2 and it has a molecular weight of approximately 698.9 g/mol[1][2]. The compound’s structure allows for diverse biological activities due to the dual functionality of the oxime (which can enhance selectivity and potency) and sulfonamide moieties (well-known for antibacterial activity via inhibition of bacterial folate synthesis)[4][5]. While specific clinical indications or mechanisms are not established for this particular molecule, derivatives in this class have shown potential anti-inflammatory and antitumor properties in addition to their classic antibacterial effects[4][7]. Oximinoarylsulfonamides are primarily used as research tools or building blocks in medicinal chemistry rather than as approved pharmaceuticals.

Other names
OXIMINOARYLSULFONAMIDEE-Oximinoarylsulfonamide
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on oximinoarylsulfonamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oximinoarylsulfonamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call